Riders · Animal Health Commission · Article VI: Natural Resources
Testing and Immunization of Employees
Rider 5 in the 2026-27 Act, page VI-15 · was rider 4
Through the session
- 2024-25 Act In current law rider 5
- Introduced (Senate) Amended rider 4
- Introduced (House) Amended rider 4
- Senate substitute Unchanged rider 4
- House substitute Unchanged rider 4
- House passed Unchanged rider 4
- Conference Unchanged rider 4
- 2026-27 Act Unchanged rider 5
Pick any two steps to compare their wording.
What changed in the text
2024-25 Act → Introduced (House): 4 passages changed.
Removed words are struck through; added words are underlined. Sources: 2024-25 Act · Introduced (House).
Every version: numbers, statuses and source pages
| Version | Rider | Against the version before | Against the current budget | Source |
|---|---|---|---|---|
| 2024-25 ActGeneral Appropriations Act, 2024-25 Biennium | 5 | First version | — | Page VI-15 |
| Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) | 4 was 5 | Amended | — | Page VI-16 |
| Introduced (House)House Bill 1 as introduced (LBB recommended, House) | 4 was 5 | Amended | — | Page VI-16 |
| Senate substituteCommittee Substitute for Senate Bill 1 | 4 | Unchanged | Amended | Page VI-14 |
| House substituteHouse Committee Substitute for Senate Bill 1 | 4 | Unchanged | Amended | Page VI-14 |
| House passedSenate Bill 1 as passed the second house | 4 | Unchanged | Amended | Page VI-14 |
| ConferenceConference Committee Report for Senate Bill 1 | 4 | Unchanged | Amended | Page VI-15 |
| 2026-27 ActGeneral Appropriations Act, 2026-27 Biennium | 5 was 4 | Unchanged | Amended | Page VI-15 |
Full text of each wording
Introduced (Senate), Introduced (House), Senate substitute, House substitute, House passed, Conference, 2026-27 Act
Source, page VI-15Testing and Immunization of Employees. Amounts appropriated above in Strategy A.1.1, Field Operations, may be expended for any immunization or testing (estimated to be $51,000 from the General Revenue Fund in each fiscal year of the 2026-27 biennium), which may be required of at- risk employees (estimated to be 110.0 full-time equivalents in each fiscal year of the 2026-27 biennium) in the performance of their duties.
2024-25 Act
Source, page VI-15Testing and Immunization of Employees. Amounts appropriated above in Strategy A.1.1, Field Operations, may be expended for any immunization or testing (estimated to be $51,000 in General Revenue in each fiscal year of the 2024-25 biennium), which may be required of at-risk employees (estimated to be 110.0 full-time equivalents in each fiscal year of the 2024-25 biennium) in the performance of their duties.